Burden of Cardiovascular Disease
A detailed analysis of the economic burden of cardiovascular disease in ESC countries, focusing on mortality, morbidity, cost containment measures, and preventive strategies to reduce the impact of CVD. The Oxford-ESC project aims to fill the gap in international data and provide rigorous evidence for policy-making and healthcare management.
Uploaded on Feb 21, 2025 | 0 Views
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Burden of Cardiovascular Disease October 2022
Burden of Cardiovascular Disease A record of the death and loss of health due to CV diseases ECONOMIC PERSPECTIVE EPIDEMIOLOGICAL/PUBLIC HEALTH It estimates the economic burden of a specific disease from the societal perspective. Morbidity The number of people in a population who are unwell or disabled, and the severity of their illness or disability Identifying the various cost components and who bears them Measuring the incidence of different cost components over the total burden (healthcare costs, non healthcare costs, productivity losses) This measures for Healthy Adjusted Life Years DALYs Disability Adjusted Life Years QALYs Quality Adjusted Life Years Explaining the costs variability across patients The results can effectively help industry, policy-makers, healthcare managers, clinicians and patients to address: Mortality The number of people in a population who die as a result of a specific disease or disability Clinical management of the disease Cost containment measures Programming healthcare services across centres/regions Developing new interventions to reduce disease progression
Burden of Cardiovascular Disease Cause of 50% of death across Europe Systematic assessment of the CVD economic burden in ESC countries from economic and epidemiological perspectives. Cost containment measures and inefficiencies Programming healthcare services across centres/regions Developing new interventions including economic models to reduce the burden of CVD 80% of premature and stroke is preventable Essential scientific and economic evidence to support adapted policies to encourage healthcare practices and management aimed to reduce the burden of CVD CVD can be prevented by addressing behavioral risk factors
Oxford-ESC Burden of cardiovascular disease While recognizing that CVD is no longer just a health issue, but a significant financial and economic hardship for individuals, health systems and societies across the globe, the BoD project aims to estimate the economic burden of cardiovascular disease in the member countries of the ESC. At present, there is a significant and undeniable lack of international, systematic and comparative evidence on the economic burden of CVD in ESC countries. The Oxford- ESC BoD project aims to fill this gap with new data, rigorously collected and validated according to highest academic standards and methodologies.
Oxford-ESC Burden of Disease project WHAT? Overview of the BoD deliverables per Work Package
Oxford-ESC BoD: HOW? Methodology WP1 WP1 will search for country-specific data on the different categories of burden of disease from international and national sources: ESC Atlas WHO Organisation for Economic Co-operation and Development (OECD), the Statistical Office of the European Communities (EUROSTAT) National Ministries of Health and statistical institutes. When relevant data cannot be obtained from these sources, articles and reports will be consulted by performing targeted literature reviews.
Oxford-ESC BoD: HOW? Methodology WP2 WP2 will focus on estimating the healthcare costs associated with selected cardiovascular diseases in ESC countries at a patient level Estimate the healthcare costs of: 1. Heart Failure 2. Atrial Fibrillation 3. Valvular Heart Disease 4. Cardiomyopathies in adults 5. Chronic Ischaemic Cardiovascular Disease 6. Acute Coronary Syndrome Examine key determinants of variation in treatment pathways, resource utilization and costs within and between countries WP2 will be initiated with the estimation of healthcare costs of Heart Failure and Atrial Fibrillation
